Taking oral caffeine supplements may significantly reduce fatigue and improve quality of life and mood in people with MS, trial results show.
Judge denies OpenAI and Microsoft's dismissal motion in Elon Musk lawsuit over nonprofit violations. Trial set for April 2026 ...
Quantum BioPharma Ltd. has successfully completed its Phase 1 clinical trial of Lucid-21-302, also known as Lucid-MS, a novel compound aimed at treating multiple sclerosis (MS). A safety review ...
AUTOIMMUNE DISEASE WITH NO CURE, BUT UNMC IS AT THE FOREFRONT OF FINDING ONE. A GROUNDBREAKING CLINICAL TRIAL IS DOING SOMETHING NO ONE ELSE EVER HAS. IT APPEARS TO BE WORKING. KETV NEWSWATCH SEVEN’S ...
Multiple sclerosis (MS) could be "on the brink of a new class of treatment" after early trial results suggest two drugs may repair damage caused by the condition. A study led by the University of ...
Three investigators and their teams have received funding for clinical trial development projects as part of the International Progressive MS Alliance’s Experimental Medicine Trial Awards. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results